x
ServiziMenu principaleHome
You are here: Home > Career Development and Opportunities > Certificates of Competence and Advanced Studies > Certificate of Competence in Breast Cancer (CCB)
Print

Certificate of Competence in Breast Cancer (CCB)

Overview

Collaborating university:  Ulm University

The Certificate of Competence in Breast cancer (CCB) was launched in 2015 and is the first competence programme to focus on the improvement of both the clinical and scientific capability of oncologists, ensuring better-quality management of breast cancer patients.

This programme, which is offered on a part-time basis over 13 months, is divided into three attendance seminars and five online modules.

Upon successful completion of the programme, participants will obtain an academic certificate issued by the European School of Oncology and Ulm University assigning 13 European Credit Transfer and Accumulation System Points (ECTS), equalling a work load of 381 hours and a diploma supplement by Ulm University.

                    

Curriculum

 

Attendance 1 

Module

Module
2

Module
3

Attendance 2

Module

Module
5

Attendance 3

Total 

Timeline

4-8 May 2021

May-July 2021
2.5 months

August-September 2021
2 months

October-November 2021

2 months

4-6 November 2021

December-mid-March 2022
3 months

Mid-March to June 2022
2.5 months

28 June - 2 July
2022

14 months 

Content

 CCB only
+
Virtual ESMO Breast
Congress

Epidemiology
and
prevention,
biology and
clinical
trials



Principles of
diagnostics,
DCIS, gene
predisposition



The breast
unit model
and LABC

CCB only
+
Virtual ABC6

Management of
early breast
cancer



Management
of advanced
breast cancer,
male BC and
supportive
therapies



 

CCB stand-
alone seminar,
including
practical
training

+
Exam
Ulm

 

Workload

 25 hrs
In-person

25 units
75 hrs
Distance
learning
+ Module test

 14 units
42 hrs
Distance
learning
+ Module test

13 units
39 hrs
Distance
learning
+ Module test

25 hrs
In-person

25 units
75 hrs
Distance
learning
+ Module test 

25 units
75 hrs
Distance
learning
+ Module test 

25 hrs
In-person
+
Certificate
exam

75 hrs
In-person
+
306 hrs
Distance
learning

381 hrs

Credits

1 ECTS 

52 units - 156 hrs

1 ECTS 

50 units - 150 hrs

1 ECTS

13 ECTS 

 

Admission and Eligibility

Admission

Admission to the Certificate of Competence in Breast Cancer programme will be by competitive application only and the selection will be based on the eligibility criteria and on the selection procedure.

Applications will be considered if received completed with all required documents and within the deadline. Attendance is limited to 25 participants.

The following documents are to be included with the application:

Curriculum vitae outlining previous education and professional experience
Copy of bachelor’s degree or equivalent degree in medicine or natural sciences or any other study programme covering the same contents
The above document should be submitted as a certified English translation
Copy of transcript of records of the examinations taken during the bachelor’s degree programme
The above document should be submitted as a certified English translation
If the point above is not applicable, record of all study achievements and examination results obtained in the course of studies until the application deadline
Proof of loss of right to take examinations or final failure in examinations in the respective programme, if applicable
Employment verification/reference letters accounting for professional experience in oncology
Personal statement, which explains why you believe you are eligible for this programme and how and why it will further support your intended career
Supporting documents to verify additional qualifications

The selection will be based on completed application documents and on the eligibility criteria.
Decisions on admissions are made by the appointed Programme Chair.

Attendance

To obtain the Certificate of Competence in Breast cancer, it will be compulsory that participants will attend all seminars and modules according to the provided timeline.

Insurance

The organisers bear no responsibility for untoward events in relation to the participation in the seminars. Participants are advised to take out their own personal and travel insurance coverage.

Eligibility

  1. Oncologists:
    1. Degree from a college or university1 in a medical course of studies or an equivalent degree at the level of at least four years of studies and
    2. At least two years of clinical experience in one of the following disciplines:
      • Medical oncology
      • Radiation oncology
      • Gynaecology
      • Senology
      • Pathology

 

  1. Natural scientists:
    1. Degree from a college or university2 in a course of studies in natural sciences or an equivalent degree at the level of at least three years of studies or in a course of studies with essentially the same contents3 at a college or university and
    2. At least two years of professional experience in oncology (medical oncology, radiation oncology, gynaecology, senology, pathology).

 

  1. The following additional achievements will increase the assessment rate of the application:
    1. Further professional experience related to the course of studies
    2. Completion of an additional qualification in oncology (specialist training as a physician or international equivalent, e.g., board certified haematologist/oncologist)
    3. Publications, as evidenced by cumulative impact factors greater than 10
    4. At least one year of relevant oncological experience in a foreign country

(1) e.g. State examination in medicine
(2) At least a bachelor’s degree
(3) Examples of courses of study with essentially the same contents are biology, molecular medicine, biochemistry and pharmacology (state examination)

Application



This programme takes place every two years and the 2021/2022 edition of this programme is already underway.

The next cohort will take place from 2023/2024, with applications opening in summer 2022.

 

 

Tuitition

The tuition fee is EUR 5,400. A discounted fee of EUR 3,000 is implemented and made available to participants from low, lower middle and upper middle-income economies as defined by The World Bank.

The tuition fee includes:

  • Access to the modules via a dedicated online learning platform
  • Access to seminars foreseen by the programme, including registration and accommodation
  • Access to all exams required by the programme
  • The administrative fee for the enrolment at Ulm University

Editorial Board

Chairs

  • Fatima Cardoso, Champalimaud Cancer Center, Lisbon, Portugal
  • Alexandru Eniu, Riviera-Chablais Hospital, Rennaz, Switzerland
  • Jens Huober, Ulm University Hospital, Ulm, Germany
  • Wolfgang Janni, Ulm University Hospital, Ulm, Germany
  • Olivia Pagani, ESO Breast Cancer Programme Coordinator and Riviera-Chablais Hospital, Rennaz, Switzerland
  • Hope Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA

Overall Scientific Director

  • Olivia Pagani, ESO Breast Cancer Programme Coordinator and Riviera-Chablais Hospital, Rennaz, Switzerland

Module Scientific Directors 

  • Module 1: Jack Cuzick, Wolfson Institute of Preventive Medicine, University of London, London, UK
  • Module 2: Tibor Tot, Uppsala University, Uppsala, Sweden
  • Module 3: Oreste Gentilini, San Raffaele University Hospital, Milan, Italy
  • Module 4: Volkmar Müller, University Medical Center Hamburg Eppendorf, Gynecology Oncology Dept., Hamburg, Germany
  • Module 5: Nadia Harbeck, Hospital of the University of Munich, Breast Centre, Dept. of Obstetrics and Gynaecology, Munich, Germany

Conceptual Development and Organisation

  • Ute Schmidt-Strassburger, Ulm University Hospital, Ulm, Germany
  • Alexandra Zampetti, ESO, Bellinzona Switzerland